Domestic animals contaminate recreational waters and drinking-water sources with excreta and pathogens; but this threat to public health is inadequately understood and is insufficiently addressed in regulations. More than 85% of the world's faecal wastes is from domestic animals such as poultry, cattle, sheep and pigs. These animals harbor zoonotic pathogens that are transported in the environment by water, especially runoff. However little information exists on health effects associated with exposure to this potential hazard to human health; and water standards focused on control of human fecal contamination do reflect the contribution of non-human fecal contamination to risk. Does compliance with current monitoring practices using microbial indicators provide protection against animal and bird sources of fecal contamination? Prepared with contributions from a group of international experts, Animal Waste, Water Quality and Human Health considers microbial contamination from domestic animal and bird sources and explores the health hazards associated with this microbial contamination and approaches to protecting public health. Animal Waste, Water Quality and Human Health will be of interest to regulators with responsibility for recreational waters, drinking water quality and water reuse; policymakers working in water quality, public health and agriculture; decision makers responsible for livestock management; and scientists and practitioners concerned with many affected subjects. Topics covered include: Credible waterborne zoonotic pathogens are discussed and ranked according to their potential hazard level. Each pathogen is described with regard to their sources, reservoirs, and infectivity. Faecal production rates of various domestic animals are discussed, alongside pathogen transmission in animal populations, pathogen prevalence in animals and "supershedders". Transport of fecal indicator organisms and their episodic occurrence in catchments. Interventions for improving food safety and reducing production losses. The impact of interventions, e.g. enhanced attenuation and storage to prevent spills; benchmarking against best management practices to reduce diffuse source contamination. Models to inform design of farm-scale best management practices and the effectiveness of best management practices for attenuating pathogen transport within catchments. The complex nature of human exposure to zoonotic waterborne pathogens; including the relationships among livestock waste contamination, water impairment, zoonotic pathogens, and human infection and illness. Human exposure interventions include case studies that discuss eradicating disease in discharging populations, adding filtration to minimal treated water to reduce Cryptosporidium occurrence and UV disinfection of beach waters to reduce beach postings. Indicators, sanitary surveys and source attribution techniques; risk assessment of exposure to zoonotic pathogens, including an interactive risk comparison approach. A review of epidemiological studies that address the relationship between swimmer illness and exposure to waters contaminated by nonhuman fecal wastes. Economic evaluation of the costs and benefits associated with animal waste management and human health.

The alternative investment market (AIM) has seen rapid growth over its 19 years, and has emerged as the market of choice for smaller, newer companies, both in the UK and abroad. However, it has often had a volatile reputation among investors, who have commonly perceived stock in the AIM as more risky than the main market. In this book, a group of leading financial analysts conduct an extensive empirical study to compare the relative volatility of two UK equity markets run by the London Stock Exchange, over a ten year period. They analyse the comparative risks involved in the alternative investment market, the market of growing companies, and the 'main market', the market for more established companies. This book analyses the volatility of the alternative investment market, using a variety of techniques and approaches. It compares the volatility of stocks in the markets, exploring variables such as size, industry, age and market switches. Using refined methods to focus on the difference between the markets, the authors provide a convincing study to challenge the idea that the alternative investment market is higher risk than the main market.

This Treasury of Prayers has four inspiring sections: Prayers Before Stem Cell Treatment (Contemplation and Decision); Prayers While at the Hospital or Clinic; Prayers for Patients with Specific Diseases, Conditions, and Disabilities (e.g. Alzheimer's disease, cancer, Parkinson's disease, heart disease, etc.); and Scriptural Readings for the Spiritual Comfort of Stem Cell Patients. From the Preface: "This book of prayers and scriptural readings is for patients who are thinking about, undergoing or recovering from stem cell treatments for the relief of disease or disability. There is a nearly universal human need to talk to God, to communicate our deepest needs, fears, desires, etc. This need may manifest itself in expressions of gratitude, of love, of wonder, of praise and glorification, and of remorse. Very often it manifests itself in please for consolation, for help, for mercy. "Each day, people all over the world are moved to worship and adore God, and to acknowledge that they are dependent upon God. The Gospels mention many times that Jesus himself often withdrew to quiet, desolate places to be alone and pray. "As St. Augustine once wrote: 'He wishes our desires to be expressed in prayers so that we may be able to receive what he is ready to give.' It is our hope that this small Treasury of Prayers will be a constant companion of patients seeking stem cell treatments and will be used frequently as an aid to beginning personal conversations with God."